Phase I/II clinical trial of concurrent radiochemotherapy in combination with topotecan for the treatment of brain metastases

By Gruschow K.   Klautke G.   Fietkau R.  

European Journal of Cancer, Vol. 38, Iss. 3, 2002-01 ,pp. : 367-374

Elsevier

Access to resources Recommend Favorite

Phase I/II study of selective cyclooxygenase-2 inhibitor celecoxib as a radiation sensitizer in patients with unresectable brain metastases

By Cerchietti Leandro   Bonomi Marcelo   Navigante Alfredo   Castro Monica   Cabalar Maria   Roth Berta  

Journal of Neuro-Oncology, Vol. 71, Iss. 1, 2005-01 ,pp. : 73-81

Springer Publishing Company

Access to resources Recommend Favorite

Phase I/II dose escalation trial of concurrent temozolomide and whole brain radiation therapy for multiple brain metastasis

By Mikkelsen Tom   Anderson Joe   Doyle Thomas   Croteau David   Avedissian Rita   Ryu Sam   Schultz Lonni  

Journal of Neuro-Oncology, Vol. 100, Iss. 2, 2010-11 ,pp. : 241-247

Springer Publishing Company

Access to resources Recommend Favorite

A Phase I/II Study of Topotecan in Combination with Carboplatin in Recurrent Epithelial Ovarian Cancer

By Bolis G.   Scarfone G.   Sciatta C.   Polverino G.P.   Rosa C.   Guarnerio P.   Parazzini F.  

Gynecologic Oncology, Vol. 83, Iss. 3, 2001-12 ,pp. : 477-480

Elsevier

Access to resources Recommend Favorite

A Phase I Study of Weekly Cisplatin and Whole Abdominal Radiation for the Treatment of Stage III and IV Endometrial Carcinoma: A Gynecologic Oncology Group Pilot Study

By Reisinger S.A.   Asbury R.   Liao S.Y.   Homesley H.D.  

Gynecologic Oncology, Vol. 63, Iss. 3, 1996-12 ,pp. : 299-303

Academic Press

Access to resources Recommend Favorite